6533b85bfe1ef96bd12ba9d5
RESEARCH PRODUCT
false
subject
0301 basic medicineMultidisciplinaryCellular differentiationmedicine.medical_treatmentT cellZAP70CD28BiologyMolecular biology03 medical and health sciences030104 developmental biology0302 clinical medicineCytokinemedicine.anatomical_structureInterferonmedicineIL-2 receptorInterleukin 1 receptor type I030215 immunologymedicine.drugdescription
Interleukin-1 (IL-1) plays a crucial role in numerous inflammatory diseases via action on its only known signaling IL-1 receptor type 1 (IL-1R1). To investigate the role of IL-1 signaling in selected cell types, we generated a new mouse strain in which exon 5 of the Il1r1 gene is flanked by loxP sites. Crossing of these mice with CD4-Cre transgenic mice resulted in IL-1R1 loss of function specifically in T cells. These mice, termed IL-1R1ΔT, displayed normal development under steady state conditions. Importantly, isolated CD4 positive T cells retained their capacity to differentiate toward Th1 or Th17 cell lineages in vitro, and strongly proliferated in cultures supplemented with either anti-CD3/CD28 or Concanavalin A, but, as predicted, were completely unresponsive to IL-1β administration. Furthermore, IL-1R1ΔT mice were protected from gut inflammation in the anti-CD3 treatment model, due to dramatically reduced frequencies and absolute numbers of IL-17A and interferon (IFN)-γ producing cells. Taken together, our data shows the necessity of intact IL-1 signaling for survival and expansion of CD4 T cells that were developed in an otherwise IL-1 sufficient environment.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-08-23 | PLOS ONE |